Our Commitment to Access

Viatris works to create sustainable access to medicine by delivering quality medicines at scale to people, regardless of geography or circumstance, through our extensive portfolio of medicines, a global, flexible and agile supply chain, and scientific expertise.

 

Supplied high quality medicines to 1 Billion patients around the world

 

Viatris access infographic

1The number of patients served is an estimate calculated using internal sales data (global volume of doses sold in 2025 in all markets as aligned with IQVIA standard units), divided by estimated per patient usage, which is based on treatment dose, treatment duration, and treatment adherence as estimated by Viatris Medical Affairs based on approved label indication and instructions for use, current international guideline recommendations, and common usage in clinical practice. Patients using multiple Viatris medicines may be counted as multiple patients. Certain adjustments were applied to account for acceptable alternatives to the patient usage factors noted above, and rounded to the nearest hundred million. Estimates may be subject to reassessment.

Our Access Goals
 

We truly believe that through our capabilities and partnerships, serving patients in more than 165 countries and territories, we can contribute to progress on the sustainable development goal #3 - health and wellbeing for all.


Providing Access to ARVs

 

Goal: Provide ARV therapy equivalent to a total of 30 million patients, including >2 million children living with HIV/AIDS, between 2022 and the end of 2025.*

Our Progress: In 2025**, we provided treatments for ~4.5 million patients, including ~281,000 children living with HIV/AIDS. Since 2022, we have provided treatments for >28.1 million patients, including >1.8 million children.


*Our ability to make progress on our goal depends on several factors, some of which are outside of our control, including the existence and funding of our distribution partners.
**The remediation activities at the Indore site have impacted our ARV therapy supply.

Promoting HCP Education and Outreach

 

Goal: Impact 100 million patients via HCP education and outreach regarding prevention, diagnosis and treatment options for cardiovascular disease, diabetes, cancer and other important chronic conditions to improve outcomes through the NCD Academy by the end of 2025.*

Our Progress: Through the end of 2025, NCD Academy is estimated to have impacted >175 million patient encounters by providing primary care clinicians around the globe with essential education and best practices for managing NCDs.*

*Patient reach is calculated at an individual HCP learner level by multiplying the number of patients treated per week, as self-reported by the individual HCP learner upon registering for NCD Academy, by the number of weeks the individual was enrolled in NCD Academy (in some cases, multiple years). Patient reach for each individual learner is summed to arrive at total patient reach. Patient reach includes unique patients as well as repeat patient encounters.

Building Access Through a Global and Flexible Supply Chain

Access to medicines depends on reliable supply and availability of medicines - the right medicine, in the right place, at the right time. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won’t get the medicines they need, when they need them. No country can make every medicine people need, and no medicine is made in every country. A secure supply of medicines from multiple regions and countries around the world is more reliable and at less risk of being disrupted. Global, diverse and flexible supply chains are key to timely and affordable access to medicine.

As an essential business, Viatris has taken actions to maintain a reliable supply of medicines, with special measures around critical medicines in times of volatile demand. Our ability to supply medicines and maintain high levels of service around the world is rooted in our global network of suppliers with a robust ability to manage shocks affecting any particular country or region. Our network allows us to offset risk and build resilience.

In 2025, our global customer service level was 92%.

Learn how a global supply chain connects people with medicines

Partnering to Shape Policies for Access

Around the world, Viatris colleagues work to address access barriers unique to the health systems they know best. By leveraging our local expertise, we can contribute to building policy solutions for long-lasting impact in communities, while also sharing our knowledge and experiences broadly across our global network to help ensure progress is made consistently, regardless of geography.

Learn more

Working to Make a Difference

Viatris Sustainability Report

We work to continuously advance responsible and sustainable practices and operations and leverage our collective expertise to empower people worldwide to live healthier at every stage of life, recognizing that our actions affect the stakeholders and communities we serve.

Read the report
Access and Global Health Fact Sheet